Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ATAC-seq in human iPSC-derived cardiomyocytes (CMs)

ABSTRACT: ATAC-seq in human iPSC-derived cardiomyocytes (CMs)

PROVIDER: PRJEB37961 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR4057001.fastq.gz	Fastqsanger.gz
	ERR4057002.fastq.gz	Fastqsanger.gz
	ERR4057003.fastq.gz	Fastqsanger.gz
	ERR4057004.fastq.gz	Fastqsanger.gz
	ERR4057005.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

ATAC-seq in human iPSC-derived cardiomyocytes (CMs)

Project description:The human iPSC line H19101 was differentiated in vitro into cardiomyocytes using a 20-day differentiation protocol (Burridge et al. 2014 PMID 24930130 and Montefiori et al 2018 PMID 29988018 ). 50,000 cardiomyocytes were used in each ATAC-seq experiment. 8 replicates were pooled to obtain the final peak file.

2020-12-01 | E-MTAB-8983 | biostudies-arrayexpress

The transcriptome of human iPSC-derived cardiomyocytes

Project description:Currently, cardiomyocytes differentiated from human induced pluripotent stem cells (iPSCs) are routinely generated for disease research and drug development as an alternative to animal models. Although iPSC-derived cardiomyocytes (iPSC-CMs) are generally assumed to resemble myocytes in the fetal heart, a systematic global comparison is still lacking. We established a robust differentiation protocol to generate mature cardiomyocytes from male and female iPSC lines, and investigated their gene expression and splicing profiles, compared to that of human hearts at different stages of development.

2025-03-30 | E-MTAB-13757 | biostudies-arrayexpress

RNA-seq of human iPSC-derived cardiomyocytes

Project description:Bulk RNA-seq of human iPSC-derived cardiomyocytes was performed to analyze transcription factors expressed in iPSC-CMs.

2023-11-16 | GSE208283 | GEO

Modeling Atrial Fibrillation (AF) in a Dish using Atrial iPSC-Derived Cardiomyocytes (iPSC-CMs)

Project description:Modeling Atrial Fibrillation (AF) in a Dish using Atrial iPSC-Derived Cardiomyocytes (iPSC-CMs)

| PRJNA645087 | ENA

iPSC-derived cardiomyocytes at the single-cell level

Project description:Currently, cardiomyocytes differentiated from human induced pluripotent stem cells (iPSCs) are routinely generated for disease research and drug development as an alternative to animal models. To assess which cell types are present at day 30 of differentiation, we conducted single-cell RNA sequencing using a female and a male line. Our analysis showed that the majority (84-87%) of cells express marker genes typical of cardiomyocytes. Most iPSC-CMs display either ventricular-like (40%) or atrial-like (35-39%) gene expression profiles, whereas a small subset (8-9%) correspond to immature, proliferative cells. The remaining cells expressed extracellular matrix genes and typical epicardial markers. Most likely, these cells underwent suboptimal WNT inhibition following mesoderm induction and differentiated along an epicardial-derived lineage, as reported previously.

2025-02-28 | E-MTAB-13850 | biostudies-arrayexpress

Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized iPSC-derived cardiomyocytes

Project description:Human pluripotent stem cell-derived cardiomyocytes (CMs) are a promising tool for cardiac cell therapy. To optimize graft cells for cardiac reconstruction, we compared the engraftment efficiency of intramyocardially-injected undifferentiated-induced pluripotent stem cells (iPSCs), day4 mesodermal cells, and day8, day20, and day30 purified iPSC-CMs after initial differentiation by tracing the engraftment ratio (ER) using in vivo bioluminescence imaging. This analysis revealed the ER of day20 CMs was significantly higher compared to other cells. Transplantation of day20 CMs into the infarcted hearts of immunodeficient mice showed significant functional improvement. Moreover, the imaging signal and ratio of Ki67-positive CMs at 3 months post injection indicated engrafted CMs proliferated in the host heart. Although this graft growth reached a plateau at 3 months, histological analysis confirmed progressive maturation from 3 to 6 months. These results suggested that day20 CMs had very high engraftment, proliferation, and therapeutic potential in host mouse hearts. Differentiated cells, N=10 Undifferentiated pluripotent stem cells, N=1 Heart samples, N=6

2016-07-03 | E-GEOD-60634 | biostudies-arrayexpress

Multiomics analysis of iPSC-derived cardiomyocytes differentiation

Project description:We collected cells at three key stages of human iPSC-derived cardiomyocytes (day 0, day 8, and day 15), and performed proteomic and ubiquitinomic analysis.

2025-09-21 | PXD068663 |

Advanced iPSC-CMs maturation by integrating maturation medium, nanopatterning, and electrical stimulation

Project description:The generation of human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) offers an unlimited source of patient-specific human cardiomyocytes. However, the use of iPSC-CM in vitro-models to guide the clinic selection of particular drugs for individual patients remains a vision. A major limitation represents the immature phenotype of iPSC-CMs, which alters their sensitivity towards physiological and pathophysiological stimuli, cardioactive drugs or toxic substances, in comparison to adult cardiomyocytes (CMs). In this study, we aim to generate iPSC-CMs with an advanced maturation state by combining the use of MM with the alignment of the cells on nanopatterned surfaces (NP) and induction of an increased contractile workload by electrical stimulation (ES). Under the combined influence of MM, NP and ES, iPSC-CMs develop a more complex cellular structure, increased mitochondrial content and enhanced electrophysiological properties. Furthermore, the response of iPSC-CMs matured under influence of MM, NP and ES to isoprenaline as well as verapamil differs to less mature iPSC-CMs cultured in B27-medium. Taken together, our results reveal that the combination of MM, NP and ES strongly improves the maturation state of iPSC-CMs and that this advanced maturation state critically affects the cell behavior in functional studies as well as response to cardioactive drugs.

| EGAS00001007491 | EGA

Modeling Atrial Fibrillation (AF) in a Dish using Atrial iPSC-Derived Cardiomyocytes (iPSC-CMs)

Project description:Our study aims to illustrate the potential use of atrial iPSC-CMs for modeling AF in a dish, elucidating the underlying cellular mechanisms, and identifying novel mechanism-based therapies custom-tailored for individual patients

2021-06-16 | GSE154084 | GEO

Analysis of human iPSC-derived cardiomyocytes

Project description:Analysis of human iPSC-derived cardiomyocytes

| PRJNA859123 | ENA